Ehrlich Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Buy
236
+5
+2% +$5.11K 0.15% 97
2026
Q1
$212K Sell
231
-8
-3% -$8.11K 0.12% 110
2025
Q4
$257K Buy
+239
New +$229K 0.15% 95
2025
Q2
Sell
-245
Closed -$202K 116
2025
Q1
$202K Buy
+245
New +$204K 0.15% 99
2024
Q4
Sell
-245
Closed -$217K 116
2024
Q3
$217K Buy
245
+9
+4% +$8.09K 0.15% 103
2024
Q2
$214K Sell
236
-40
-14% -$32K 0.17% 98
2024
Q1
$215K Buy
+276
New +$196K 0.18% 93

Other funds holding LLY

Ehrlich Financial Group's LLY Position: Q2 2026 in Review

Ehrlich Financial Group increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $5.11K and bringing the position to 236 shares worth $283K. The position accounts for 0.15% of the portfolio, ranked #97.

Ehrlich Financial Group first reported a position in LLY in Q1 2024 and has held it in 7 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ehrlich Financial Group held 236 shares of Eli Lilly worth $283K as of Q2 2026.
  • Ehrlich Financial Group bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.15% of Ehrlich Financial Group's portfolio in Q2 2026, its #97 holding.
  • Ehrlich Financial Group first reported a position in Eli Lilly in Q1 2024 and has held it in 7 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ehrlich Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.